Zingmond David S, McGory Marcia L, Ko Clifford Y
Division of General Internal Medicine and Health Services Research, Department of Medicine, The David Geffen School of Medicine at the University of California Los Angeles, Los Angeles 90095-1736, USA.
JAMA. 2005 Oct 19;294(15):1918-24. doi: 10.1001/jama.294.15.1918.
The use of Roux-en-Y gastric bypass (RYGB) has been reported to be effective in the treatment of obesity and its related comorbidities. Utilization of inpatient services after RYGB is less well understood.
To determine the rates and indications for inpatient hospital use before and after RYGB.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective study of Californians receiving RYGB in California hospitals from 1995 to 2004.
Hospitalization in the 1 to 3 years after RYGB.
In California from 1995 to 2004, 60,077 patients underwent RYGB-11,659 in 2004 alone. The rate of hospitalization in the year following RYGB was more than double the rate in the year preceding RYGB (19.3% vs 7.9%, P<.001). Furthermore, in the subset of patients (n = 24,678) with full 3-year follow-up, a mean of 8.4% were admitted a year before RYGB while 20.2% were readmitted in the year after RYGB, 18.4% in the second year after RYGB, and 14.9% in the third year after RYGB. The most common reasons for admission prior to RYGB were obesity-related problems (eg, osteoarthritis, lower extremity cellulitis), and elective operation (eg, hysterectomy), while the most common reasons for admission after RYGB were complications often thought to be procedure related, such as ventral hernia repair and gastric revision. In multivariate logistic regression models predicting 1-year readmission after RYGB, increasing Charlson Comorbidity Index score, and hospitalization in the 3-year period prior to RYGB were significantly associated with readmission within a year.
Increases in hospital use after surgery appear to be related to RYGB. Payers, clinicians, and patients must consider the not-inconsequential rate of rehospitalization after this type of surgery.
据报道,Roux-en-Y胃旁路术(RYGB)在治疗肥胖症及其相关合并症方面有效。RYGB术后住院服务的利用情况尚不太清楚。
确定RYGB术前和术后住院治疗的发生率及指征。
设计、地点和参与者:对1995年至2004年在加利福尼亚州医院接受RYGB的加利福尼亚人进行回顾性研究。
RYGB术后1至3年的住院情况。
1995年至2004年在加利福尼亚州,60,077例患者接受了RYGB手术,仅2004年就有11,659例。RYGB术后一年的住院率比术前一年的住院率高出一倍多(19.3%对7.9%,P<0.001)。此外,在有完整3年随访的患者亚组(n = 24,678)中,RYGB术前一年平均有8.4%的患者入院,而RYGB术后一年有20.2%的患者再次入院,RYGB术后第二年为18.4%,术后第三年为14.9%。RYGB术前最常见的入院原因是肥胖相关问题(如骨关节炎、下肢蜂窝织炎)和择期手术(如子宫切除术),而RYGB术后最常见的入院原因是通常被认为与手术相关的并发症,如腹疝修补术和胃修复术。在预测RYGB术后1年再次入院的多变量逻辑回归模型中,Charlson合并症指数评分增加以及RYGB术前3年期间的住院治疗与1年内再次入院显著相关。
手术后住院率的增加似乎与RYGB有关。支付方、临床医生和患者必须考虑这类手术后不可忽视的再住院率。